View ValuationUmicore 将来の成長Future 基準チェック /16Umicoreの収益は年間41.3%で減少すると予測されていますが、年間利益は年間5.9%で増加すると予測されています。EPS は年間 増加すると予測されています。自己資本利益率は 3 年後に14.8% 4.5%なると予測されています。主要情報5.9%収益成長率4.51%EPS成長率Chemicals 収益成長20.8%収益成長率-41.3%将来の株主資本利益率14.84%アナリストカバレッジGood最終更新日21 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 06Umicore Announces Supervisory Board AppointmentsUmicore at its ordinary and extraordinary shareholders’ meeting held on April 30th 2026 approved the appointment of Anna Bertona and Benjamin Loh as new Supervisory Board members for a term of 3 years.Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €20.34, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Europe. Total loss to shareholders of 24% over the past three years.Declared Dividend • May 04Dividend of €0.35 announcedShareholders will receive a dividend of €0.35. Ex-date: 5th May 2026 Payment date: 7th May 2026 Dividend yield will be 2.1%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (31% earnings payout ratio) and cash flows (31% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. EPS is expected to grow by 8.8% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 03Umicore Sa Announces Chief Financial Officer Changes, Effective August 1, 2026Umicore SA announced the appointment of Lily Liu as Chief Financial Officer effective August 1, 2026. Mrs. Liu succeeds current CFO Wannes Peferoen who will leave the Company after twenty years of dedicated service. Post handover on August 1st, Mr. Peferoen will serve in a special advisory capacity until February 28, 2027 to ensure a seamless transition. Mrs. Liu joins Umicore from Synthomer, a specialty chemicals company listed on the London Stock Exchange, where she serves as CFO since July 2022. Holding both British and Australian citizenship, she brings more than twenty years of financial leadership experience across the chemicals, manufacturing, and engineering industries. Before her time at Synthomer, Mrs. Liu was CFO at Essentra plc, and previously held CFO positions with Xaar plc and Smiths Detection. She is also a non-executive director and audit committee member at DCC plc.Reported Earnings • Mar 31Full year 2025 earnings released: EPS: €1.60 (vs €6.15 loss in FY 2024)Full year 2025 results: EPS: €1.60 (up from €6.15 loss in FY 2024). Revenue: €19.4b (up 30% from FY 2024). Net income: €384.5m (up €1.86b from FY 2024). Profit margin: 2.0% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue is expected to decline by 41% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.1%. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.お知らせ • Mar 30Umicore SA, Annual General Meeting, Apr 30, 2026Umicore SA, Annual General Meeting, Apr 30, 2026, at 17:00 Romance Standard Time.Reported Earnings • Feb 21Full year 2025 earnings released: EPS: €1.60 (vs €6.15 loss in FY 2024)Full year 2025 results: EPS: €1.60 (up from €6.15 loss in FY 2024). Revenue: €19.4b (up 30% from FY 2024). Net income: €384.5m (up €1.86b from FY 2024). Profit margin: 2.0% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue is expected to decline by 56% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.Buy Or Sell Opportunity • Dec 18Now 27% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to €17.53. The fair value is estimated to be €13.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to decline by 37% per annum. Earnings are forecast to grow by 22% per annum over the same time period.Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €14.83, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in Europe. Total loss to shareholders of 53% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.95 per share.お知らせ • Oct 17+ 1 more updateUmicore SA to Report Fiscal Year 2025 Final Results on Mar 27, 2026Umicore SA announced that they will report fiscal year 2025 final results on Mar 27, 2026Buy Or Sell Opportunity • Sep 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to €14.42. The fair value is estimated to be €11.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to decline by 41% per annum. Earnings are forecast to grow by 21% per annum over the same time period.お知らせ • Aug 22Umicore SA to Report Fiscal Year 2025 Results on Feb 20, 2026Umicore SA announced that they will report fiscal year 2025 results on Feb 20, 2026Reported Earnings • Aug 04First half 2025 earnings released: EPS: €0.57 (vs €6.12 loss in 1H 2024)First half 2025 results: EPS: €0.57 (up from €6.12 loss in 1H 2024). Revenue: €8.69b (up 17% from 1H 2024). Net income: €136.7m (up €1.61b from 1H 2024). Profit margin: 1.6% (up from net loss in 1H 2024). Revenue is expected to decline by 42% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.2%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.New Risk • Aug 03New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 16% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (8.1% average weekly change). Minor Risks Dividend is not well covered by cash flows (213% cash payout ratio). Large one-off items impacting financial results.New Risk • Jun 24New major risk - Revenue and earnings growthEarnings have declined by 44% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.9% average weekly change). Earnings have declined by 44% per year over the past 5 years. Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.New Risk • May 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Austrian stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.9% average weekly change). Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.Upcoming Dividend • Apr 21Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 28 April 2025. Payment date: 30 April 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 6.5%. Within top quartile of Austrian dividend payers (5.4%). Higher than average of industry peers (2.8%).Reported Earnings • Mar 23Full year 2024 earnings released: €6.15 loss per share (vs €1.60 profit in FY 2023)Full year 2024 results: €6.15 loss per share (down from €1.60 profit in FY 2023). Revenue: €14.9b (down 19% from FY 2023). Net loss: €1.48b (down 484% from profit in FY 2023). Revenue is expected to decline by 40% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 4.4%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.お知らせ • Mar 21Umicore Announces Supervisory Board ChangesUmicore at its ordinary and special shareholders’ meetings to be held on April 24, 2025 announced after serving 10 years on Umicore’s Supervisory Board, Mr. Mark Garrett announced that he will not seek to renew his mandate at the upcoming 2025 ordinary shareholders’ meeting. Mr. Laurent Raets, Groupe Bruxelles Lambert (GBL), also announced his intention to step down from the Supervisory Board, after having served 6 years on the Board.Declared Dividend • Feb 24Final dividend of €0.17 announcedShareholders will receive a dividend of €0.17. Ex-date: 28th April 2025 Payment date: 30th April 2025 Dividend yield will be 3.8%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (42% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.お知らせ • Feb 17Umicore SA, Annual General Meeting, Apr 30, 2025Umicore SA, Annual General Meeting, Apr 30, 2025.お知らせ • Feb 15Umicore Sa Proposes Annual Dividend, Payable on April 30, 2025Umicore SA's Supervisory Board will propose a gross annual dividend of €0.50 per share for 2024 at the Annual General Meeting on 24 April 2025. This is a reduction from the €0.80 per share paid for 2023. Considering the interim dividend of €0.25 per share paid in August 2024, a gross amount of €0.25 per share will be paid on 30 April 2025, subject to shareholder approval. Based on the closing share price on 31 December 2024 of €9.96, the dividend yield amounts to approximately 5%.Reported Earnings • Feb 14Full year 2024 earnings released: €6.15 loss per share (vs €1.60 profit in FY 2023)Full year 2024 results: €6.15 loss per share (down from €1.60 profit in FY 2023). Revenue: €14.9b (down 19% from FY 2023). Net loss: €1.48b (down 484% from profit in FY 2023). Revenue is expected to decline by 39% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 4.3%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.お知らせ • Feb 14Umicore SA to Report Fiscal Year 2024 Final Results on Mar 21, 2025Umicore SA announced that they will report fiscal year 2024 final results on Mar 21, 2025お知らせ • Feb 01Umicore SA to Report First Half, 2025 Results on Aug 01, 2025Umicore SA announced that they will report first half, 2025 results on Aug 01, 2025お知らせ • Dec 23+ 2 more updatesUmicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350Umicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350お知らせ • Sep 23Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)Upcoming Dividend • Aug 15Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2024. Payment date: 21 August 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 7.2%. Within top quartile of Austrian dividend payers (6.0%). Higher than average of industry peers (2.7%).Declared Dividend • Jul 31First half dividend of €0.17 announcedShareholders will receive a dividend of €0.17. Ex-date: 19th August 2024 Payment date: 21st August 2024 Dividend yield will be 4.4%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (57% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time.Reported Earnings • Jul 28First half 2024 earnings released: €6.12 loss per share (vs €0.93 profit in 1H 2023)First half 2024 results: €6.12 loss per share (down from €0.93 profit in 1H 2023). Revenue: €7.52b (down 25% from 1H 2023). Net loss: €1.47b (down €1.70b from profit in 1H 2023). Revenue is expected to decline by 43% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 4.4%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 29 percentage points per year, which is a significant difference in performance.New Risk • Jul 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 70% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (6.7% average weekly change). Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.お知らせ • Jul 26Umicore SA to Report Fiscal Year 2024 Results on Feb 14, 2025Umicore SA announced that they will report fiscal year 2024 results on Feb 14, 2025Valuation Update With 7 Day Price Move • Jun 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €13.56, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in Europe. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €13.17 per share.New Risk • Jun 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 4.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.4% average weekly change). Earnings are forecast to decline by an average of 4.6% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (122% cash payout ratio).お知らせ • May 16Umicore Announces Chief Executive Officer ChangesUmicore announced the appointment of Bart Sap as Chief Executive Officer, effective May 16th. He will succeed Mathias Miedreich who has decided to step down, in mutual agreement with the Supervisory Board. Bart Sap joined Umicore in 2004 and has been the Executive Vice President Catalysis since March 2021. His nomination is in line with the company's established succession plan. Mathias Miedreich will remain available for advice to Umicore during the next several months. Bart Sap was appointed Executive Vice-President Catalysis on March 1st, 2021. He joined Umicore in 2004 as controller for Cobalt & Specialty Materials and, after successive assignments in Korea and Belgium covering finance, supply and refining of battery raw materials, business development and operations, he became Senior Vice-President for Cobalt & Specialty Materials and Supply at the beginning of 2020. Bart holds a Master’s Degree in Commercial Science from Vlekho in Brussels, Belgium, with majors in Accountancy and Taxation.お知らせ • Apr 27+ 1 more updateUmicore Announces Supervisory Board Appointments, Effective 1 November 2024 and Appoints Frédéric Oudéa as Member of Nomination, Remuneration and Sustainability CommitteeUmicore at its ordinary and special shareholders’ meetings held on April 25, 2024, appointed Frédéric Oudéa and Philip Eykerman as new Supervisory Board members for a term of 3 years, with effect from 1 November 2024. Mr. Oudéa also joins the company’s Nomination & Remuneration Committee and its Sustainability Committee.Upcoming Dividend • Apr 22Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 02 May 2024. Payout ratio is a comfortable 50% but the company is paying out more than the cash it is generating. Trailing yield: 3.8%. Lower than top quartile of Austrian dividend payers (5.8%). Higher than average of industry peers (2.7%).お知らせ • Mar 26Umicore SA Announces Board ChangesMr. Mario Armero announced his intention to step down from the Supervisory Board at the end of this 2024 Annual General Meeting, after having served for a total of 4 years on the Board. The Supervisory Board proposes the appointment of Mr. Frédéric Oudéaas a new Supervisory Board member to replace Mr. Armero for a term of 3 years. Upon his appointment, Mr. Oudéa will also join Umicore's Nomination & Remuneration Committee and its Sustainability Committee. Frédéric Oudéa, a French citizen, is a graduate of the École Polytechnique and the École Nationale d'administration. He spent most of his career in the banking sector, at Société Générale, where he was appointed CEO from 2008 till 2023. He is currently chairman of Sanofi and senior independent director of Capgemini. He is also senior executive advisor to GBL Group.Declared Dividend • Feb 26Final dividend of €0.39 announcedShareholders will receive a dividend of €0.39. Ex-date: 29th April 2024 Payment date: 1st January 1970 Dividend yield will be 2.8%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (50% earnings payout ratio) but not covered by cash flows (122% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Feb 18Full year 2023 earnings released: EPS: €1.60 (vs €2.37 in FY 2022)Full year 2023 results: EPS: €1.60 (down from €2.37 in FY 2022). Revenue: €18.4b (down 28% from FY 2022). Net income: €385.1m (down 32% from FY 2022). Profit margin: 2.1% (in line with FY 2022). Revenue is expected to decline by 37% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.8%. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.お知らせ • Feb 16+ 3 more updatesUmicore Proposes Dividend for the Year 2023, Payable on May 2024Umicore proposed gross annual dividend for 2023 of €0.80 of which €0.55 to be paid in May 2024, with an interim dividend of €0.25 already paid out in August 2023.Upcoming Dividend • Aug 11Upcoming dividend of €0.17 per share at 3.0% yieldEligible shareholders must have bought the stock before 18 August 2023. Payment date: 22 August 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 3.0%. Lower than top quartile of Austrian dividend payers (5.5%). Lower than average of industry peers (4.1%).New Risk • Aug 09New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 0.8% per year for the foreseeable future. Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Aug 02First half 2023 earnings released: EPS: €0.93 (vs €1.29 in 1H 2022)First half 2023 results: EPS: €0.93 (down from €1.29 in 1H 2022). Revenue: €10.0b (down 22% from 1H 2022). Net income: €223.2m (down 28% from 1H 2022). Profit margin: 2.2% (down from 2.4% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 53% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.0%. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.お知らせ • Jul 29Umicore SA Announces Interim Dividend, Payable on 22 August 2023Umicore SA announced interim dividend of €0.25 per share, payable on 22 August 2023 with Ex-interim dividend trading date of 18 August 2023 and Record date for the interim dividend of 21 August 2023.Upcoming Dividend • Apr 25Upcoming dividend of €0.39 per share at 2.7% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 04 May 2023. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 2.7%. Lower than top quartile of Austrian dividend payers (5.2%). Lower than average of industry peers (3.8%).Reported Earnings • Mar 30Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.4b (up 5.7% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 45% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.2%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 21Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.6b (up 6.5% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 54% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.2%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Feb 16Umicore SA Proposes Gross Annual Dividend for 2022, Payable on 4 May 2023Umicore SA proposed gross annual dividend for 2022 of €0.80 of which €0.55 to be paid in May 2023, with an interim dividend of €0.25 already paid out in August 2022. Ex-dividend trading date is 2 May 2023. Record date for the dividend is 3 May 2023 and payable date is 4 May 2023.お知らせ • Jan 26+ 2 more updatesUmicore SA, Annual General Meeting, Apr 27, 2023Umicore SA, Annual General Meeting, Apr 27, 2023.Upcoming Dividend • Aug 12Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2022. Payment date: 23 August 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Austrian dividend payers (5.2%). Lower than average of industry peers (3.6%).お知らせ • Aug 05Umicore SA Announces Interim Dividend, Payable on August 23, 2022Umicore SA announced on 29 July 2022, a gross interim dividend of €0.25 per share will be paid out on 23 August 2022. This represents a dividend of €0.175 net of withholding tax. The share will be traded ex coupon as from 19 August 2022. The record date will be 22 August 2022.Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.29 (vs €1.66 in 1H 2021)First half 2022 results: EPS: €1.29 (down from €1.66 in 1H 2021). Revenue: €13.8b (up 9.2% from 1H 2021). Net income: €309.1m (down 23% from 1H 2021). Profit margin: 2.2% (down from 3.2% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 83% compared to a 15% growth forecast for the industry in Austria. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 30Umicore SA to Report Fiscal Year 2022 Results on Feb 16, 2023Umicore SA announced that they will report fiscal year 2022 results on Feb 16, 2023お知らせ • May 02+ 1 more updateUmicore SA Appoints Alison Henwood as Independent Supervisory Board MemberUmicore SA announced at the AGM held on 28 April 2022, the shareholders approved appointment of Alison Henwood as a new, independent Supervisory Board member for a term of 3 years.Upcoming Dividend • Apr 28Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 02 May 2022. Payment date: 04 May 2022. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of Austrian dividend payers (4.9%). Lower than average of industry peers (3.2%).Reported Earnings • Mar 28Full year 2021 earnings released: EPS: €2.57 (vs €0.54 in FY 2020)Full year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.1b (up 16% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 83% compared to a 14% growth forecast for the industry in Austria. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.2b (up 17% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.5%. Over the next year, revenue is expected to shrink by 83% compared to a 9.3% growth forecast for the industry in Austria. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Feb 16+ 1 more updateUmicore SA to Report Fiscal Year 2021 Results on Mar 25, 2022Umicore SA announced that they will report fiscal year 2021 results on Mar 25, 2022Valuation Update With 7 Day Price Move • Dec 13Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €36.74, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.74 per share.Upcoming Dividend • Aug 13Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 20 August 2021. Payment date: 24 August 2021. Trailing yield: 1.3%. Lower than top quartile of Austrian dividend payers (3.3%). Lower than average of industry peers (2.3%).Reported Earnings • Aug 02First half 2021 earnings released: EPS €1.66 (vs €0.38 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €12.7b (up 27% from 1H 2020). Net income: €400.1m (up 340% from 1H 2020). Profit margin: 3.2% (up from 0.9% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has increased by 1% per year.お知らせ • Jun 10Umicore SA (ENXTBR:UMI) made an offer to acquire the remaining 8.79% stake in Allgemeine Gold- und Silberscheideanstalt AG (MUN:AGS) for approximately €140 million.Umicore SA (ENXTBR:UMI) made an offer to acquire the remaining 8.79% stake in Allgemeine Gold- und Silberscheideanstalt AG (MUN:AGS) for approximately €140 million on June 9, 2021.お知らせ • Apr 30Umicore SA Announces Annual Dividend Payment to Be Paid on 5 May 2021Umicore SA announced that the payment of a gross annual dividend of €0.75 per share. Taking into account the gross interim dividend of €0.25 per share paid out on 25 August 2020, a gross amount of €0.50 per share (ISIN BE0974320526) will be paid out on 5 May 2021.Upcoming Dividend • Apr 26Upcoming dividend of €0.35 per shareEligible shareholders must have bought the stock before 03 May 2021. Payment date: 05 May 2021. Trailing yield: 2.0%. Lower than top quartile of Austrian dividend payers (3.2%). Lower than average of industry peers (2.4%).Is New 90 Day High Low • Mar 01New 90-day high: €49.20The company is up 27% from its price of €38.74 on 01 December 2020. The Austrian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.33 per share.Reported Earnings • Feb 13Full year 2020 earnings released: EPS €0.54 (vs €1.20 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: €20.7b (up 18% from FY 2019). Net income: €130.5m (down 55% from FY 2019). Profit margin: 0.6% (down from 1.6% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has remained flat, which means it is well ahead of earnings.お知らせ • Feb 11+ 2 more updatesUmicore SA, Annual General Meeting, Apr 29, 2021Umicore SA, Annual General Meeting, Apr 29, 2021.お知らせ • Jan 29Umicore SA to Report Fiscal Year 2020 Results on Feb 11, 2021Umicore SA announced that they will report fiscal year 2020 results at 7:30 AM, Central European Standard Time on Feb 11, 2021Is New 90 Day High Low • Jan 18New 90-day high: €46.80The company is up 35% from its price of €34.64 on 20 October 2020. The Austrian market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €15.50 per share.Is New 90 Day High Low • Dec 29New 90-day high: €39.38The company is up 10.0% from its price of €35.65 on 30 September 2020. The Austrian market is up 29% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.32 per share.Is New 90 Day High Low • Oct 21New 90-day low: €34.07The company is down 25% from its price of €45.29 on 23 July 2020. The Austrian market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.46 per share.Is New 90 Day High Low • Sep 25New 90-day low: €35.32The company is down 15% from its price of €41.46 on 26 June 2020. The Austrian market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.29 per share.業績と収益の成長予測WBAG:UMI - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20283,992470313811812/31/20273,9224212407301012/31/20263,7843903526601012/31/202519,388385386711N/A9/30/202517,753257221590N/A6/30/202516,11512957470N/A3/31/202515,492-676172669N/A12/31/202414,869-1,480287869N/A9/30/202415,292-1,3953131,015N/A6/30/202415,715-1,3103401,160N/A3/31/202416,998-4632491,102N/A12/31/202318,2803851581,043N/A9/30/202320,4264352764N/A6/30/202322,571484-153486N/A3/31/202324,010527-5560N/A12/31/202225,449570143634N/A9/30/202224,863549307771N/A6/30/202224,278528470908N/A3/31/202224,1725736561,083N/A12/31/202124,0666198431,259N/A9/30/202123,7465297241,155N/A6/30/202123,4274406051,052N/A3/31/202122,072285352790N/A12/31/202020,71613199528N/A9/30/202020,29818050506N/A6/30/202019,8802301483N/A3/31/202018,687259-49481N/A12/31/201917,494288-99479N/A9/30/201916,223296N/A333N/A6/30/201914,953304N/A187N/A3/31/201914,339311N/A80N/A12/31/201813,726317N/A-27N/A9/30/201812,895291N/A53N/A6/30/201812,063265N/A133N/A3/31/201812,010240N/A143N/A12/31/201711,957215N/A153N/A9/30/201711,913204N/A211N/A6/30/201711,870194N/A268N/A3/31/201711,157187N/A326N/A12/31/201610,444181N/A385N/A9/30/20169,957175N/A384N/A6/30/20169,471168N/A382N/A3/31/20169,584161N/A324N/A12/31/20159,698153N/A265N/A9/30/20159,957175N/A263N/A6/30/20159,161170N/A253N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: UMIの予測収益成長率 (年間5.9% ) は 貯蓄率 ( 2.3% ) を上回っています。収益対市場: UMIの収益 ( 5.9% ) Austrian市場 ( 11.3% ) よりも低い成長が予測されています。高成長収益: UMIの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: UMIの収益は今後 3 年間で減少すると予想されています (年間-41.3% )。高い収益成長: UMIの収益は今後 3 年間で減少すると予測されています (年間-41.3% )。一株当たり利益成長率予想将来の株主資本利益率将来のROE: UMIの 自己資本利益率 は、3年後には低くなると予測されています ( 14.8 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 00:11終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Umicore SA 12 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。33 アナリスト機関Rupesh MadlaniBarclaysJames StewartBarclaysSebastian BrayBerenberg30 その他のアナリストを表示
お知らせ • May 06Umicore Announces Supervisory Board AppointmentsUmicore at its ordinary and extraordinary shareholders’ meeting held on April 30th 2026 approved the appointment of Anna Bertona and Benjamin Loh as new Supervisory Board members for a term of 3 years.
Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €20.34, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Europe. Total loss to shareholders of 24% over the past three years.
Declared Dividend • May 04Dividend of €0.35 announcedShareholders will receive a dividend of €0.35. Ex-date: 5th May 2026 Payment date: 7th May 2026 Dividend yield will be 2.1%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (31% earnings payout ratio) and cash flows (31% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. EPS is expected to grow by 8.8% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 03Umicore Sa Announces Chief Financial Officer Changes, Effective August 1, 2026Umicore SA announced the appointment of Lily Liu as Chief Financial Officer effective August 1, 2026. Mrs. Liu succeeds current CFO Wannes Peferoen who will leave the Company after twenty years of dedicated service. Post handover on August 1st, Mr. Peferoen will serve in a special advisory capacity until February 28, 2027 to ensure a seamless transition. Mrs. Liu joins Umicore from Synthomer, a specialty chemicals company listed on the London Stock Exchange, where she serves as CFO since July 2022. Holding both British and Australian citizenship, she brings more than twenty years of financial leadership experience across the chemicals, manufacturing, and engineering industries. Before her time at Synthomer, Mrs. Liu was CFO at Essentra plc, and previously held CFO positions with Xaar plc and Smiths Detection. She is also a non-executive director and audit committee member at DCC plc.
Reported Earnings • Mar 31Full year 2025 earnings released: EPS: €1.60 (vs €6.15 loss in FY 2024)Full year 2025 results: EPS: €1.60 (up from €6.15 loss in FY 2024). Revenue: €19.4b (up 30% from FY 2024). Net income: €384.5m (up €1.86b from FY 2024). Profit margin: 2.0% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue is expected to decline by 41% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.1%. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 30Umicore SA, Annual General Meeting, Apr 30, 2026Umicore SA, Annual General Meeting, Apr 30, 2026, at 17:00 Romance Standard Time.
Reported Earnings • Feb 21Full year 2025 earnings released: EPS: €1.60 (vs €6.15 loss in FY 2024)Full year 2025 results: EPS: €1.60 (up from €6.15 loss in FY 2024). Revenue: €19.4b (up 30% from FY 2024). Net income: €384.5m (up €1.86b from FY 2024). Profit margin: 2.0% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue is expected to decline by 56% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
Buy Or Sell Opportunity • Dec 18Now 27% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to €17.53. The fair value is estimated to be €13.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to decline by 37% per annum. Earnings are forecast to grow by 22% per annum over the same time period.
Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €14.83, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in Europe. Total loss to shareholders of 53% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.95 per share.
お知らせ • Oct 17+ 1 more updateUmicore SA to Report Fiscal Year 2025 Final Results on Mar 27, 2026Umicore SA announced that they will report fiscal year 2025 final results on Mar 27, 2026
Buy Or Sell Opportunity • Sep 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to €14.42. The fair value is estimated to be €11.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to decline by 41% per annum. Earnings are forecast to grow by 21% per annum over the same time period.
お知らせ • Aug 22Umicore SA to Report Fiscal Year 2025 Results on Feb 20, 2026Umicore SA announced that they will report fiscal year 2025 results on Feb 20, 2026
Reported Earnings • Aug 04First half 2025 earnings released: EPS: €0.57 (vs €6.12 loss in 1H 2024)First half 2025 results: EPS: €0.57 (up from €6.12 loss in 1H 2024). Revenue: €8.69b (up 17% from 1H 2024). Net income: €136.7m (up €1.61b from 1H 2024). Profit margin: 1.6% (up from net loss in 1H 2024). Revenue is expected to decline by 42% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.2%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
New Risk • Aug 03New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 16% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (8.1% average weekly change). Minor Risks Dividend is not well covered by cash flows (213% cash payout ratio). Large one-off items impacting financial results.
New Risk • Jun 24New major risk - Revenue and earnings growthEarnings have declined by 44% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.9% average weekly change). Earnings have declined by 44% per year over the past 5 years. Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.
New Risk • May 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Austrian stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.9% average weekly change). Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.
Upcoming Dividend • Apr 21Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 28 April 2025. Payment date: 30 April 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 6.5%. Within top quartile of Austrian dividend payers (5.4%). Higher than average of industry peers (2.8%).
Reported Earnings • Mar 23Full year 2024 earnings released: €6.15 loss per share (vs €1.60 profit in FY 2023)Full year 2024 results: €6.15 loss per share (down from €1.60 profit in FY 2023). Revenue: €14.9b (down 19% from FY 2023). Net loss: €1.48b (down 484% from profit in FY 2023). Revenue is expected to decline by 40% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 4.4%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
お知らせ • Mar 21Umicore Announces Supervisory Board ChangesUmicore at its ordinary and special shareholders’ meetings to be held on April 24, 2025 announced after serving 10 years on Umicore’s Supervisory Board, Mr. Mark Garrett announced that he will not seek to renew his mandate at the upcoming 2025 ordinary shareholders’ meeting. Mr. Laurent Raets, Groupe Bruxelles Lambert (GBL), also announced his intention to step down from the Supervisory Board, after having served 6 years on the Board.
Declared Dividend • Feb 24Final dividend of €0.17 announcedShareholders will receive a dividend of €0.17. Ex-date: 28th April 2025 Payment date: 30th April 2025 Dividend yield will be 3.8%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (42% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.
お知らせ • Feb 17Umicore SA, Annual General Meeting, Apr 30, 2025Umicore SA, Annual General Meeting, Apr 30, 2025.
お知らせ • Feb 15Umicore Sa Proposes Annual Dividend, Payable on April 30, 2025Umicore SA's Supervisory Board will propose a gross annual dividend of €0.50 per share for 2024 at the Annual General Meeting on 24 April 2025. This is a reduction from the €0.80 per share paid for 2023. Considering the interim dividend of €0.25 per share paid in August 2024, a gross amount of €0.25 per share will be paid on 30 April 2025, subject to shareholder approval. Based on the closing share price on 31 December 2024 of €9.96, the dividend yield amounts to approximately 5%.
Reported Earnings • Feb 14Full year 2024 earnings released: €6.15 loss per share (vs €1.60 profit in FY 2023)Full year 2024 results: €6.15 loss per share (down from €1.60 profit in FY 2023). Revenue: €14.9b (down 19% from FY 2023). Net loss: €1.48b (down 484% from profit in FY 2023). Revenue is expected to decline by 39% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 4.3%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 14Umicore SA to Report Fiscal Year 2024 Final Results on Mar 21, 2025Umicore SA announced that they will report fiscal year 2024 final results on Mar 21, 2025
お知らせ • Feb 01Umicore SA to Report First Half, 2025 Results on Aug 01, 2025Umicore SA announced that they will report first half, 2025 results on Aug 01, 2025
お知らせ • Dec 23+ 2 more updatesUmicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350Umicore SA(ENXTBR:UMI) dropped from S&P EUROPE 350
お知らせ • Sep 23Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD)
Upcoming Dividend • Aug 15Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2024. Payment date: 21 August 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 7.2%. Within top quartile of Austrian dividend payers (6.0%). Higher than average of industry peers (2.7%).
Declared Dividend • Jul 31First half dividend of €0.17 announcedShareholders will receive a dividend of €0.17. Ex-date: 19th August 2024 Payment date: 21st August 2024 Dividend yield will be 4.4%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (57% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time.
Reported Earnings • Jul 28First half 2024 earnings released: €6.12 loss per share (vs €0.93 profit in 1H 2023)First half 2024 results: €6.12 loss per share (down from €0.93 profit in 1H 2023). Revenue: €7.52b (down 25% from 1H 2023). Net loss: €1.47b (down €1.70b from profit in 1H 2023). Revenue is expected to decline by 43% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 4.4%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 29 percentage points per year, which is a significant difference in performance.
New Risk • Jul 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 70% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (6.7% average weekly change). Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making.
お知らせ • Jul 26Umicore SA to Report Fiscal Year 2024 Results on Feb 14, 2025Umicore SA announced that they will report fiscal year 2024 results on Feb 14, 2025
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €13.56, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in Europe. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €13.17 per share.
New Risk • Jun 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 4.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.4% average weekly change). Earnings are forecast to decline by an average of 4.6% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (122% cash payout ratio).
お知らせ • May 16Umicore Announces Chief Executive Officer ChangesUmicore announced the appointment of Bart Sap as Chief Executive Officer, effective May 16th. He will succeed Mathias Miedreich who has decided to step down, in mutual agreement with the Supervisory Board. Bart Sap joined Umicore in 2004 and has been the Executive Vice President Catalysis since March 2021. His nomination is in line with the company's established succession plan. Mathias Miedreich will remain available for advice to Umicore during the next several months. Bart Sap was appointed Executive Vice-President Catalysis on March 1st, 2021. He joined Umicore in 2004 as controller for Cobalt & Specialty Materials and, after successive assignments in Korea and Belgium covering finance, supply and refining of battery raw materials, business development and operations, he became Senior Vice-President for Cobalt & Specialty Materials and Supply at the beginning of 2020. Bart holds a Master’s Degree in Commercial Science from Vlekho in Brussels, Belgium, with majors in Accountancy and Taxation.
お知らせ • Apr 27+ 1 more updateUmicore Announces Supervisory Board Appointments, Effective 1 November 2024 and Appoints Frédéric Oudéa as Member of Nomination, Remuneration and Sustainability CommitteeUmicore at its ordinary and special shareholders’ meetings held on April 25, 2024, appointed Frédéric Oudéa and Philip Eykerman as new Supervisory Board members for a term of 3 years, with effect from 1 November 2024. Mr. Oudéa also joins the company’s Nomination & Remuneration Committee and its Sustainability Committee.
Upcoming Dividend • Apr 22Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 02 May 2024. Payout ratio is a comfortable 50% but the company is paying out more than the cash it is generating. Trailing yield: 3.8%. Lower than top quartile of Austrian dividend payers (5.8%). Higher than average of industry peers (2.7%).
お知らせ • Mar 26Umicore SA Announces Board ChangesMr. Mario Armero announced his intention to step down from the Supervisory Board at the end of this 2024 Annual General Meeting, after having served for a total of 4 years on the Board. The Supervisory Board proposes the appointment of Mr. Frédéric Oudéaas a new Supervisory Board member to replace Mr. Armero for a term of 3 years. Upon his appointment, Mr. Oudéa will also join Umicore's Nomination & Remuneration Committee and its Sustainability Committee. Frédéric Oudéa, a French citizen, is a graduate of the École Polytechnique and the École Nationale d'administration. He spent most of his career in the banking sector, at Société Générale, where he was appointed CEO from 2008 till 2023. He is currently chairman of Sanofi and senior independent director of Capgemini. He is also senior executive advisor to GBL Group.
Declared Dividend • Feb 26Final dividend of €0.39 announcedShareholders will receive a dividend of €0.39. Ex-date: 29th April 2024 Payment date: 1st January 1970 Dividend yield will be 2.8%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (50% earnings payout ratio) but not covered by cash flows (122% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Feb 18Full year 2023 earnings released: EPS: €1.60 (vs €2.37 in FY 2022)Full year 2023 results: EPS: €1.60 (down from €2.37 in FY 2022). Revenue: €18.4b (down 28% from FY 2022). Net income: €385.1m (down 32% from FY 2022). Profit margin: 2.1% (in line with FY 2022). Revenue is expected to decline by 37% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.8%. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
お知らせ • Feb 16+ 3 more updatesUmicore Proposes Dividend for the Year 2023, Payable on May 2024Umicore proposed gross annual dividend for 2023 of €0.80 of which €0.55 to be paid in May 2024, with an interim dividend of €0.25 already paid out in August 2023.
Upcoming Dividend • Aug 11Upcoming dividend of €0.17 per share at 3.0% yieldEligible shareholders must have bought the stock before 18 August 2023. Payment date: 22 August 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 3.0%. Lower than top quartile of Austrian dividend payers (5.5%). Lower than average of industry peers (4.1%).
New Risk • Aug 09New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 0.8% per year for the foreseeable future. Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Aug 02First half 2023 earnings released: EPS: €0.93 (vs €1.29 in 1H 2022)First half 2023 results: EPS: €0.93 (down from €1.29 in 1H 2022). Revenue: €10.0b (down 22% from 1H 2022). Net income: €223.2m (down 28% from 1H 2022). Profit margin: 2.2% (down from 2.4% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 53% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.0%. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
お知らせ • Jul 29Umicore SA Announces Interim Dividend, Payable on 22 August 2023Umicore SA announced interim dividend of €0.25 per share, payable on 22 August 2023 with Ex-interim dividend trading date of 18 August 2023 and Record date for the interim dividend of 21 August 2023.
Upcoming Dividend • Apr 25Upcoming dividend of €0.39 per share at 2.7% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 04 May 2023. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 2.7%. Lower than top quartile of Austrian dividend payers (5.2%). Lower than average of industry peers (3.8%).
Reported Earnings • Mar 30Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.4b (up 5.7% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 45% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.2%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 21Full year 2022 earnings released: EPS: €2.37 (vs €2.57 in FY 2021)Full year 2022 results: EPS: €2.37 (down from €2.57 in FY 2021). Revenue: €25.6b (up 6.5% from FY 2021). Net income: €569.9m (down 7.9% from FY 2021). Profit margin: 2.2% (down from 2.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 54% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Europe are expected to grow by 3.2%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Feb 16Umicore SA Proposes Gross Annual Dividend for 2022, Payable on 4 May 2023Umicore SA proposed gross annual dividend for 2022 of €0.80 of which €0.55 to be paid in May 2023, with an interim dividend of €0.25 already paid out in August 2022. Ex-dividend trading date is 2 May 2023. Record date for the dividend is 3 May 2023 and payable date is 4 May 2023.
お知らせ • Jan 26+ 2 more updatesUmicore SA, Annual General Meeting, Apr 27, 2023Umicore SA, Annual General Meeting, Apr 27, 2023.
Upcoming Dividend • Aug 12Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 19 August 2022. Payment date: 23 August 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Austrian dividend payers (5.2%). Lower than average of industry peers (3.6%).
お知らせ • Aug 05Umicore SA Announces Interim Dividend, Payable on August 23, 2022Umicore SA announced on 29 July 2022, a gross interim dividend of €0.25 per share will be paid out on 23 August 2022. This represents a dividend of €0.175 net of withholding tax. The share will be traded ex coupon as from 19 August 2022. The record date will be 22 August 2022.
Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.29 (vs €1.66 in 1H 2021)First half 2022 results: EPS: €1.29 (down from €1.66 in 1H 2021). Revenue: €13.8b (up 9.2% from 1H 2021). Net income: €309.1m (down 23% from 1H 2021). Profit margin: 2.2% (down from 3.2% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 83% compared to a 15% growth forecast for the industry in Austria. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 30Umicore SA to Report Fiscal Year 2022 Results on Feb 16, 2023Umicore SA announced that they will report fiscal year 2022 results on Feb 16, 2023
お知らせ • May 02+ 1 more updateUmicore SA Appoints Alison Henwood as Independent Supervisory Board MemberUmicore SA announced at the AGM held on 28 April 2022, the shareholders approved appointment of Alison Henwood as a new, independent Supervisory Board member for a term of 3 years.
Upcoming Dividend • Apr 28Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 02 May 2022. Payment date: 04 May 2022. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of Austrian dividend payers (4.9%). Lower than average of industry peers (3.2%).
Reported Earnings • Mar 28Full year 2021 earnings released: EPS: €2.57 (vs €0.54 in FY 2020)Full year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.1b (up 16% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 83% compared to a 14% growth forecast for the industry in Austria. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: €2.57 (up from €0.54 in FY 2020). Revenue: €24.2b (up 17% from FY 2020). Net income: €619.0m (up 374% from FY 2020). Profit margin: 2.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.5%. Over the next year, revenue is expected to shrink by 83% compared to a 9.3% growth forecast for the industry in Austria. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Feb 16+ 1 more updateUmicore SA to Report Fiscal Year 2021 Results on Mar 25, 2022Umicore SA announced that they will report fiscal year 2021 results on Mar 25, 2022
Valuation Update With 7 Day Price Move • Dec 13Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €36.74, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €38.74 per share.
Upcoming Dividend • Aug 13Upcoming dividend of €0.17 per shareEligible shareholders must have bought the stock before 20 August 2021. Payment date: 24 August 2021. Trailing yield: 1.3%. Lower than top quartile of Austrian dividend payers (3.3%). Lower than average of industry peers (2.3%).
Reported Earnings • Aug 02First half 2021 earnings released: EPS €1.66 (vs €0.38 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €12.7b (up 27% from 1H 2020). Net income: €400.1m (up 340% from 1H 2020). Profit margin: 3.2% (up from 0.9% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has increased by 1% per year.
お知らせ • Jun 10Umicore SA (ENXTBR:UMI) made an offer to acquire the remaining 8.79% stake in Allgemeine Gold- und Silberscheideanstalt AG (MUN:AGS) for approximately €140 million.Umicore SA (ENXTBR:UMI) made an offer to acquire the remaining 8.79% stake in Allgemeine Gold- und Silberscheideanstalt AG (MUN:AGS) for approximately €140 million on June 9, 2021.
お知らせ • Apr 30Umicore SA Announces Annual Dividend Payment to Be Paid on 5 May 2021Umicore SA announced that the payment of a gross annual dividend of €0.75 per share. Taking into account the gross interim dividend of €0.25 per share paid out on 25 August 2020, a gross amount of €0.50 per share (ISIN BE0974320526) will be paid out on 5 May 2021.
Upcoming Dividend • Apr 26Upcoming dividend of €0.35 per shareEligible shareholders must have bought the stock before 03 May 2021. Payment date: 05 May 2021. Trailing yield: 2.0%. Lower than top quartile of Austrian dividend payers (3.2%). Lower than average of industry peers (2.4%).
Is New 90 Day High Low • Mar 01New 90-day high: €49.20The company is up 27% from its price of €38.74 on 01 December 2020. The Austrian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.33 per share.
Reported Earnings • Feb 13Full year 2020 earnings released: EPS €0.54 (vs €1.20 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: €20.7b (up 18% from FY 2019). Net income: €130.5m (down 55% from FY 2019). Profit margin: 0.6% (down from 1.6% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
お知らせ • Feb 11+ 2 more updatesUmicore SA, Annual General Meeting, Apr 29, 2021Umicore SA, Annual General Meeting, Apr 29, 2021.
お知らせ • Jan 29Umicore SA to Report Fiscal Year 2020 Results on Feb 11, 2021Umicore SA announced that they will report fiscal year 2020 results at 7:30 AM, Central European Standard Time on Feb 11, 2021
Is New 90 Day High Low • Jan 18New 90-day high: €46.80The company is up 35% from its price of €34.64 on 20 October 2020. The Austrian market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €15.50 per share.
Is New 90 Day High Low • Dec 29New 90-day high: €39.38The company is up 10.0% from its price of €35.65 on 30 September 2020. The Austrian market is up 29% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.32 per share.
Is New 90 Day High Low • Oct 21New 90-day low: €34.07The company is down 25% from its price of €45.29 on 23 July 2020. The Austrian market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.46 per share.
Is New 90 Day High Low • Sep 25New 90-day low: €35.32The company is down 15% from its price of €41.46 on 26 June 2020. The Austrian market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.29 per share.